First 100% Bioavailable Resveratrol Supplement from Phase4 Pharmaceutical
February 2014 – Phase4 Pharmaceutical – AgeForce® Division introduces the first 100% bioavailable resveratrol supplement in a transdermal time-release patch.
HALLANDALE BEACH, Fla., Feb. 19, 2014 /PRNewswire-iReach/ — The Problem: Less than 1% of any orally ingested resveratrol supplement survives digestive stomach acid, intestinal bacteria, and first-pass liver functions, before entering the bloodstream.
The Solution: According to the company’s CEO Steve Lapidus: “We needed to bypass the digestive system and the liver to deliver a clinically effective dosage of resveratrol to one’s bloodstream. To accomplish this we developed, and are now marketing via our website a transdermal time-release patch that delivers a 75mg dose of trans-resveratrol directly to one’s bloodstream. Bioavailability with our patch is 100% as compared to 1% when take orally! A person would have to ingest 7,500mg at a minimum orally to get the equivalent dosage of our transdermal time-release patch into their bloodstream! This is the first time that the health & fitness conscience consumer can effectively get the proven benefits of this remarkable substance!”
There are many clinical trials and peer review studies that support the benefits of trans-resveratrol to include:
-- Longevity -- Obesity -- Powerful Antioxidant -- Elevates Energy & Endurance -- May Help To Prevent Certain Cancers & Cure -- Reduced Risk Of Heart Disease -- Anti Diabetic Effects -- Skin Protection -- May Help To Protect Against Alzheimer's Disease and Huntington's Disease -- Anti-Inflammatory -- Antiviral (herpes simplex virus and others) -- Elevates Testosterone Levels -- Opioid Tolerance Reduction
About: Phase4 Pharmaceutical – AgeForce® Division develops and sells health and fitness supplements featuring transdermal time-release direct to bloodstream delivery worldwide. To assure pharmaceutical efficacy and quality, the company formulates and manufactures all of their supplements exclusively in the United States.
Bioavailability Barriers Of Resveratrol – Wikipedia – Resveratrol Bioavailability Of Resveratrol N.Y. Acad. Sci. ISSN 0077-8923
Media Contact: Stephen Lapidus, Phase4 Pharmaceutical, 305 788 6604, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Phase4 Pharmaceutical